| Identification | Back Directory | [Name]
(R)-2-((5-(1H-indazol-5-yl)pyridin-3-yl)amino)-2-phenylethan-1-ol Benzeneethanol, beta-[[5-(1H-indazol-5-yl)-3-pyridinyl]amino]-, (betaR)- | [CAS]
1613638-82-6 | [Synonyms]
CDK8-IN-4
(R)-2-((5-(1H-indazol-5-yl)pyridin-3-yl)amino)-2-phenylethan-1-ol Benzeneethanol, beta-[[5-(1H-indazol-5-yl)-3-pyridinyl]amino]-, (betaR)- | [Molecular Formula]
C20H18N4O | [MDL Number]
MFCD31657394 | [MOL File]
1613638-82-6.mol | [Molecular Weight]
330.39 |
| Chemical Properties | Back Directory | [Boiling point ]
631.2±55.0 °C(Predicted) | [density ]
1.329±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
13.20±0.40(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Description]
VFN38826, also known as CDK8-IN-4, is a CDK8 inhibitor. VFN38826 was first reported in patent WO2014090692A1, compound example 16, with an IC50 of 0.2 nM. This product has no formal name at the moment. | [Uses]
CDK8-IN-4 is an inhibitor of CDK8 extracted from patent WO2014090692A1, compound example 16, with an IC50 of 0.2 nM. | [References]
[1] Cheng Z, et al. Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer. WO2014090692A1 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|